Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Buy
94,672
+16,495
+21% +$1.9M 0.13% 111
2026
Q1
$9.33M Sell
78,177
-1,890
-2% -$248K 0.13% 117
2025
Q4
$10.9M Buy
80,067
+1,561
+2% +$225K 0.15% 89
2025
Q3
$11.6M Buy
78,506
+507
+0.7% +$70.3K 0.16% 89
2025
Q2
$10.1M Buy
77,999
+13,090
+20% +$1.59M 0.16% 87
2025
Q1
$7.9M Sell
64,909
-15,386
-19% -$1.91M 0.17% 85
2024
Q4
$9.44M Buy
+80,295
New +$10.2M 0.23% 64

Other funds holding XYL

Groupe la Francaise's XYL Position: Q2 2026 in Review

Groupe la Francaise increased its Xylem (XYL) stake by 21% in Q2 2026, buying an estimated $1.9M and bringing the position to 94,672 shares worth $11.2M. The position accounts for 0.13% of the portfolio, ranked #111.

Groupe la Francaise first reported a position in XYL in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.6M in Q3 2025. 1,103 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Groupe la Francaise held 94,672 shares of Xylem worth $11.2M as of Q2 2026.
  • Groupe la Francaise bought 16,495 Xylem shares in Q2 2026, an estimated $1.9M.
  • Xylem made up 0.13% of Groupe la Francaise's portfolio in Q2 2026, its #111 holding.
  • Groupe la Francaise first reported a position in Xylem in Q4 2024 and has held it in 7 quarters since.
  • Groupe la Francaise's Xylem position peaked at $11.6M in Q3 2025.
  • 1,103 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.